168 related articles for article (PubMed ID: 17362052)
1. Rivastigmine in Parkinson's disease dementia: profile report.
Siddiqui MA; Wagstaff AJ
Drugs Aging; 2007; 24(3):255-9. PubMed ID: 17362052
[No Abstract] [Full Text] [Related]
2. Rivastigmine for dementia associated with Parkinson's disease.
Harada CN; Shega JW; Sachs GA
N Engl J Med; 2005 Mar; 352(13):1387; author reply 1387. PubMed ID: 15800242
[No Abstract] [Full Text] [Related]
3. Rivastigmine in Parkinson's disease dementia.
Chitnis S; Rao J
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
[TBL] [Abstract][Full Text] [Related]
4. Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.
Barone P; Burn DJ; van Laar T; Hsu C; Poewe W; Lane RM
Mov Disord; 2008 Aug; 23(11):1532-40. PubMed ID: 18581467
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia.
Schmitt FA; Farlow MR; Meng X; Tekin S; Olin JT
CNS Neurosci Ther; 2010 Dec; 16(6):330-6. PubMed ID: 20950329
[TBL] [Abstract][Full Text] [Related]
6. Rivastigmine for dementia associated with Parkinson's disease.
Morgan J; Sethi KD
Curr Neurol Neurosci Rep; 2005 Jul; 5(4):263-5. PubMed ID: 15987609
[No Abstract] [Full Text] [Related]
7. First treatment for dementia of Parkinson's disease.
FDA Consum; 2006; 40(5):5. PubMed ID: 17328100
[No Abstract] [Full Text] [Related]
8. Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study.
Emre M; Poewe W; De Deyn PP; Barone P; Kulisevsky J; Pourcher E; van Laar T; Storch A; Micheli F; Burn D; Durif F; Pahwa R; Callegari F; Tenenbaum N; Strohmaier C
Clin Neuropharmacol; 2014; 37(1):9-16. PubMed ID: 24434526
[TBL] [Abstract][Full Text] [Related]
9. Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.
Dujardin K; Devos D; Duhem S; Destée A; Marié RM; Durif F; Lacomblez L; Touchon J; Pollak P; Péré JJ
J Neurol; 2006 Sep; 253(9):1154-9. PubMed ID: 16998649
[TBL] [Abstract][Full Text] [Related]
10. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension.
Oertel W; Poewe W; Wolters E; De Deyn PP; Emre M; Kirsch C; Hsu C; Tekin S; Lane R
Drug Saf; 2008; 31(1):79-94. PubMed ID: 18095748
[TBL] [Abstract][Full Text] [Related]
11. [Lewy body dementia and Parkinson disease dementia].
Meyniel C; Damier P
Presse Med; 2007 Oct; 36(10 Pt 2):1485-90. PubMed ID: 17572053
[TBL] [Abstract][Full Text] [Related]
12. Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease.
Wesnes K
Drugs Today (Barc); 2007 Jun; 43(6):349-59. PubMed ID: 17612707
[TBL] [Abstract][Full Text] [Related]
13. Rivastigmine: in Parkinson's disease dementia.
Siddiqui MA; Wagstaff AJ
CNS Drugs; 2006; 20(9):739-47; discussion 748-50. PubMed ID: 16953649
[TBL] [Abstract][Full Text] [Related]
14. Rivastigmine for dementia associated with Parkinson's disease.
Emre M; Aarsland D; Albanese A; Byrne EJ; Deuschl G; De Deyn PP; Durif F; Kulisevsky J; van Laar T; Lees A; Poewe W; Robillard A; Rosa MM; Wolters E; Quarg P; Tekin S; Lane R
N Engl J Med; 2004 Dec; 351(24):2509-18. PubMed ID: 15590953
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease dementia--a first step?
Press DZ
N Engl J Med; 2004 Dec; 351(24):2547-9. PubMed ID: 15590960
[No Abstract] [Full Text] [Related]
16. [Treatment of degenerative dementia disorders--who should be treated?].
Hasselbalch SG; Kampmann JP
Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
[TBL] [Abstract][Full Text] [Related]
17. Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients.
Fogelson N; Kogan E; Korczyn AD; Giladi N; Shabtai H; Neufeld MY
Acta Neurol Scand; 2003 Apr; 107(4):252-5. PubMed ID: 12675697
[TBL] [Abstract][Full Text] [Related]
18. Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
Bullock R; Cameron A
Curr Med Res Opin; 2002; 18(5):258-64. PubMed ID: 12240787
[TBL] [Abstract][Full Text] [Related]
19. Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.
Devos D; Moreau C; Maltête D; Lefaucheur R; Kreisler A; Eusebio A; Defer G; Ouk T; Azulay JP; Krystkowiak P; Witjas T; Delliaux M; Destée A; Duhamel A; Bordet R; Defebvre L; Dujardin K
J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):668-74. PubMed ID: 24218528
[TBL] [Abstract][Full Text] [Related]
20. Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
Gurevich TY; Shabtai H; Korczyn AD; Simon ES; Giladi N
Mov Disord; 2006 Oct; 21(10):1663-6. PubMed ID: 16941467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]